SELLAS Life Sciences Group, Inc. short interest in 2026
In 2026, SELLAS Life Sciences Group, Inc.'s disclosed short interest ran from 29.52% of shares outstanding on 15 Jan 2026 to 29.25% on 15 Sep 2026, a change of -0.27 percentage points. The year's high was 35.28% on 15 Jun 2026 and its low 27.91% on 14 Aug 2026, averaging 31.42% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.63 days on 15 Apr 2026. Full history: SELLAS Life Sciences Group, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 29.52% (15 Jan 2026)
- End of year
- 29.25% (15 Sep 2026)
- Change
- -0.27 pp
- High
- 35.28% (15 Jun 2026)
- Low
- 27.91% (14 Aug 2026)
- Average
- 31.42%
- Highest days to cover
- 13.63 (15 Apr 2026)
- SEC filings marked
- 8
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 29.52% | 2.59 | results (8-K) |
| 30 Jan 2026 | 29.02% | 6.26 | |
| 13 Feb 2026 | 32.33% | 10.01 | |
| 27 Feb 2026 | 34.49% | 7.79 | |
| 13 Mar 2026 | 32.15% | 6.25 | |
| 31 Mar 2026 | 29.81% | 5.96 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 31.54% | 13.63 | |
| 30 Apr 2026 | 31.82% | 11.68 | |
| 15 May 2026 | 31.78% | 7.14 | 10-Q filed, results (8-K) |
| 29 May 2026 | 33.97% | 4.42 | |
| 15 Jun 2026 | 35.28% | 9.25 | |
| 30 Jun 2026 | 35.25% | 4.75 | |
| 15 Jul 2026 | 30.78% | 5.93 | |
| 31 Jul 2026 | 30.61% | 7.89 | results (8-K) |
| 14 Aug 2026 | 27.91% | 10.44 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 28.68% | 6.88 | |
| 15 Sep 2026 | 29.25% | 8.60 |
See also: SELLAS Life Sciences Group, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.